 LAFAYETTE, La., Oct. 28, 2020 GLOBE NEWSWIRE -- Viemed Healthcare, Inc. the Company or Viemed TSX: VMD.TO and NASDAQ:VMD, a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced its support for the Centers for Medicare Medicaid Services CMS recent decision to remove oxygen and positive airway pressure PAP devices from the Competitive Bidding Program CBP beginning January 1, 2021. CMS intended for 16 product categories to be included in the Round 2021 CBP. However, as previously disclosed, non-invasive ventilators were removed from the 2021 CBP in April 2020. Now, CMS has dropped 13 of the 15 remaining product categories, including oxygen and PAP therapies. CMS is only awarding CBP contracts for the off-the-shelf OTS Back Braces and OTS Knee Braces product categories. CMSs stated its reason for not awarding these 13 product categories was because the payment amounts did not achieve expected savings. 